Senior Finance Officer J11905
description of job
1. Assist department managers to handle related expense calculations, quarterly analysis reports, product specific analysis, cost structure analysis, etc .;
2. Performance accounting, sorting out market activities, sorting out performance accounting rules;
3. Assist department managers in branch and regional docking work. '
1. Intermediate professional title, passing relevant qualifications such as certified public accountant, registered tax accountant is preferred;
2. Have good Excel and PPT processing ability, good communication and coordination ability;
3. Has a good financial and taxation background, and can submit solutions based on branch and regional characteristics;
4, can quickly improve the competence of the sales finance team in the new era;
5. Able to adapt to short-term business trips (about 10 days per month).
Zhengda Tianqing Pharmaceutical Group is an innovative pharmaceutical group enterprise integrating scientific research, production and sales. It is a well-known domestic R & D and production base for liver health drugs. It is a key national high-tech enterprise and a national torch plan Lianyungang new pharmaceutical industry base. Backbone enterprises, ranked 16th in the Top 100 Chinese Pharmaceutical Industry Enterprises in 2016 (selected and released by China Pharmaceutical Industry Information Center).
Zhengda Tianqing always regards scientific and technological innovation as an important strategy for enterprise development, and is one of the pharmaceutical companies with a large investment in innovative drug research in China. Zhengda Tianqing regards the research institute as the innovation carrier, and has established high-level R & D platforms such as "Jiangsu New Liver Disease Engineering and Technology Research Center", "Postdoctoral Research Station", and "Nationally Recognized Enterprise Technology Center", and has continuously enhanced its independent innovation capabilities. With the development of enterprises and the enhancement of R & D capabilities, Zhengda Tianqing has invested more than 1 billion yuan in R & D expenses and will gradually align with multinational companies. At present, the institute has more than 180 research projects, including more than 30 new drugs and more than 20 biological drugs.
Zhengda Tianqing has three production bases in Lianyungang, covering a total area of more than 800 acres, including a hatching base covering an area of 160 acres, an API base covering over 200 acres, and a preparation base covering 480 acres. Zhengda Tianqing Preparation Base obtained the country's first new GMP certificate. The solid preparation workshop passed the European Union certification and the EU-approved GMP certificate issued by the German Drug Administration. The obtaining of these certificates indicates that the quality and management level of pharmaceutical production of enterprises are at the forefront of the national pharmaceutical industry. At present, Chia Tai Tianqing is preparing for the four major fist products to enter the international market. In the future, these drugs will become a new weapon for Chia Tai Tianqing to crack the international market.
The field of treatment of Zhengda Tianqing products involves liver disease, tumor, respiratory, infection, digestion and other diseases. 16 products with annual sales of over 100 million yuan have formed a "product group of 100 million yuan", of which products with annual sales of over 2 billion yuan 2 These are the national first-class new medicine magnesium isoglycyrrhizinate injection (Tianqing Ganmei) and the first domestic marketed entecavir dispersible tablet (Runzhong). In addition to the field of strong liver disease, a unique product line has also been formed in the field of anti-tumor. The blood tumor products decitabine, imatinib, and dasatinib are the first in the country; the solid tumor product capecitabine was approved for marketing Anlotinib, the original and innovative drug in the Chinese tumor field that has attracted much attention, is officially on the market and is expected to become the standard drug for third-line treatment of patients with advanced non-small cell lung cancer. Respiratory, antibiotic, endocrine and other fields will also be the focus of the company's future development.
In the future development, Zhengda Tianqing Pharmaceutical will continue to strengthen the building of core competitiveness, establish a sound scientific and efficient research and development system, so that the company's research and development level is always in line with the international frontier. Develop the company into a large-scale pharmaceutical group with the scientific research strength among the top five pharmaceutical companies in the country and the top ten in the country with comprehensive strength; and launch an internationalization strategy to build the company into a scientific and technological, pharmaceutical-based international company.
Lianyungang City Address: No. 369 Yuzhou South Road, Lianyungang City, Nanjing Address: Building 9, District 699-8, Xuanwu Avenue, Xuanwu District, Nanjing (Xuzhuang Software Park R & D Zone 1)
Job posting company
Zhengda Tianqing Pharmaceutical Group Co., Ltd.
Enterprise nature: joint venture
Enterprise size: 10,000 or more
Year of establishment: 1997
Enterprise website: http://www.cttq.com
Business Address: 369 Yuzhou South Road
- 医药代表（日照）J12036 6001-8000 Medical Representative (Rizhao) J12036
- 临床监查员-武汉J11409 6001-8000 clinical monitor-Wuhan J11409
- 医药代表（天门）J11957 8001-10000 Medical Representative (Tianmen) J11957
- 研发岗/实验岗J12051 8001-10000 R & D post / experiment post J12051
- 临床监查员（IIT/IV）（上海）J11631 8001-10000 Clinical Supervisor (IIT / IV) (Shanghai) J11631
- 临床监查员（IIT/IV）（苏州）J12048 8001-10000 Clinical Supervisor (IIT / IV) (Suzhou) J12048
- 研发系统管理工程师J11955 8001-10000 R & D system management engineer J11955
- 临床监查员-昆明J11682 6001-8000 Clinical Supervisor-Kunming J11682
- 商业代表（广东）J11414 6001-8000 Business Representative (Guangdong) J11414
- 商业代表（深圳）J12028 6001-8000 Business Representative (Shenzhen) J12028
Related job recommendations
区域经理 省区经理 业务员（医疗线） 特色专科项目运营总监 地区经理（江苏） 终端经理（普二线） 终端经理（医疗线） 冻干粉针剂车间工艺员 检测员（普二线） 检测员（医疗线） Relevant positions in Jiangsu: Regional manager, provincial manager, salesperson (medical line), specialty specialty project operation director, regional manager (Jiangsu), terminal manager (general line), terminal manager (medical line), freeze-dried powder injection workshop, process technician (general line) Inspector (medical line)
吉林万通药业集团药品经销有限公司 江苏吉贝尔药业有限公司 鱼跃医疗 徐州新沂市钟吾医院 丽珠医药集团股份有限公司 无锡道生中医文化发展有限公司 广东众生药业股份有限公司苏北办事处 江苏大丰同仁医院 江苏南中医丰盛健康城有限公司 江苏南京溧水区中医院 Jiangsu Recruitment Enterprise: Jilin Wantong Pharmaceutical Group Pharmaceutical Distribution Co., Ltd.Jiangsu Jibel Pharmaceutical Co., Ltd.Yueyue Medical Co., Ltd.Xuzhou Xinyi Zhongwu Hospital Lizhu Pharmaceutical Group Co. , Ltd. North Jiangsu Co., Ltd. Jiangsu Dafeng Tongren Hospital Jiangsu South Traditional Chinese Medicine Fengsheng Health City Co., Ltd. Traditional Chinese Medicine Hospital of Wushui District , Nanjing , Jiangsu